A randomized phase II trial of 5-fluorouracil, with or without human interferon-β, for advanced colorectal cancer

This study compared the efficacy and safety of 5-fluorouracil (5-FU) monotherapy to that of 5-FU combined with natural human interferon-β (IFN-β) in patients with unresectable, advanced colorectal carcinoma. Forty-nine chemotherapy-naive patients were randomized to 5-FU alone or to the combination....

Descripción completa

Detalles Bibliográficos
Autores principales: Villar-Grimalt, A, Candel, M T, Massuti, B, Lizón, J, Sánchez, B, Frau, A, Gorostidi, B, Goedkoop, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362283/
https://www.ncbi.nlm.nih.gov/pubmed/10360656
http://dx.doi.org/10.1038/sj.bjc.6690422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362283/
https://www.ncbi.nlm.nih.gov/pubmed/10360656
http://dx.doi.org/10.1038/sj.bjc.6690422

Ejemplares similares